Tumor-Specific Activity of Precision Medicines in the NCI-MATCH Trial.

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2024)

These findings support the value of basket trials because even when precision medicines do not have tumor-agnostic activity, basket trials can identify tumor-specific activity for future study.

Keyphrases

clinical trial
phase iii
phase ii